Medicare Enrolled

Dr. John Stasiewicz, MD

Family Medicine · Irvine, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
4050 BARRANCA PKWY, Irvine, CA 92604
9495511090
In practice since 2005 (20 years)
NPI: 1033100482 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Stasiewicz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Stasiewicz? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Stasiewicz

Dr. John Stasiewicz is a family medicine specialist in Irvine, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Stasiewicz performed 635 Medicare services across 406 unique beneficiaries.

Between the years covered by Open Payments, Dr. Stasiewicz received a total of $7,728 from 45 pharmaceutical and/or device companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Stasiewicz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 35% volume in CA $7,728 industry payments

Medicare Practice Summary

Medicare Utilization ↗
635
Medicare services
Top 35% in CA for family medicine
406
Unique beneficiaries
$44
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~32 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
224 $51 $203
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
179 $6 $6
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
109 $54 $288
Betamethasone steroid injection
An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate.
23 $5 $15
Pneumococcal conjugate vaccine (PCV20)
An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria.
21 $282 $638
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
20 $34 $51
Joint injection, major joint
Removal of fluid from a large joint and/or injection of medication into the joint space.
16 $52 $144
Flu vaccine, high-dose
High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe.
16 $72 $168
Pneumonia vaccine administration
This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider.
15 $34 $51
Electrocardiogram (EKG), 12-lead
A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report.
12 $12 $81
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$7,728
Total received (2018-2024)
Avg $1,288/year across 6 years
Top 5% in CA for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
45
Companies
400
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,728 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,879
2023
$1,885
2022
$510
2020
$293
2019
$1,382
2018
$1,779

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim Pharmaceuticals, Inc.
$293
AstraZeneca Pharmaceuticals LP
$253
Novo Nordisk Inc
$252
GlaxoSmithKline, LLC.
$224
Lilly USA, LLC
$207
ABBVIE INC.
$189
PFIZER INC.
$77
Amgen Inc.
$65
Merck Sharp & Dohme LLC
$64
Exact Sciences Corporation
$62
SK Life Science, Inc.
$50
UCB, Inc.
$42
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Dynavax Technologies Corporation
$24
SANOFI PASTEUR INC.
$17
IDORSIA PHARMACEUTICALS US INC
$15
JAZZ PHARMACEUTICALS INC.
$15
Top 3 companies account for 42.5% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$1,188
Lilly USA, LLC
$831
Boehringer Ingelheim Pharmaceuticals, Inc.
$824
GlaxoSmithKline, LLC.
$769
Novo Nordisk Inc
$528
Amgen Inc.
$381
SANOFI-AVENTIS U.S. LLC
$353
Merck Sharp & Dohme Corporation
$336
Janssen Pharmaceuticals, Inc
$303
PFIZER INC.
$291
AbbVie Inc.
$278
ABBVIE INC.
$189
SK Life Science, Inc.
$187
Exact Sciences Corporation
$137
Gilead Sciences, Inc.
$114
Merck Sharp & Dohme LLC
$99
SANOFI PASTEUR INC.
$93
IDORSIA PHARMACEUTICALS US INC
$88
Sanofi Pasteur Inc.
$62
Lucid Diagnostics Inc.
$45
Myriad Genetic Laboratories, Inc.
$45
Amarin Pharma Inc.
$44
UCB, Inc.
$42
MDD US Operations, LLC
$39
Seqirus USA Inc
$37
Teva Pharmaceuticals USA, Inc.
$34
MITSUBISHI TANABE PHARMA AMERICA, INC.
$29
Biogen, Inc.
$28
Bausch Health US, LLC
$26
Dexcom, Inc.
$25
Dynavax Technologies Corporation
$24
Neurocrine Biosciences, Inc.
$24
Hologic, LLC
$23
kaleo, Inc.
$22
Medtronic USA, Inc.
$22
Xeris Pharmaceuticals, Inc.
$21
Metuchen Pharmaceuticals
$19
Abbott Laboratories
$18
Allergan, Inc.
$17
Allergan Inc.
$17
MannKind Corporation
$17
Sunovion Pharmaceuticals Inc.
$16
Bayer HealthCare Pharmaceuticals Inc.
$15
JAZZ PHARMACEUTICALS INC.
$15
Fidia Pharma USA Inc.
$13
Top 3 companies account for 36.8% of all-time payments
Associated products mentioned in payments ›
ADVAIR · AFREZZA · AIRSUPRA · AJOVY · AMYVID · ANORO · APLENZIN · APTIOM · AREXVY · AUSTEDO · AUVI-Q · AVONEX · Aimovig · BEXSERO · BEYFORTUS · BOTOX · BREO · CHANTIX · COLOGUARD · COMIRNATY · CYLTEZO · Cologuard Collection Kit · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · EVUSHELD · Enbrel · FARXIGA · FASENRA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FLUZONE QUADRIVALENT · FreeStyle Libre · GARDASIL · GOCOVRI · GVOKE PFS · HYMOVIS · Heplisav-B · INTELLIS · INVOKANA · JANUVIA · JARDIANCE · KISUNLA · Kyleena · LINZESS · LYRICA · MOUNJARO · MYRISK · NUCALA · NURTEC ODT · OFEV · Ongentys · Otezla · Ozempic · PNEUMOVAX 23 · PREVNAR - 13 · QULIPTA · QUVIVIQ · RADICAVA · ROTATEQ · Rybelsus · Rystiggo · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STEGLATRO · STIOLTO RESPIMAT · SYMBICORT · Stendra · THINPREP 2000 PROCESSOR · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRULICITY · Tresiba · UBRELVY · VAXELIS · Vascepa · Victoza · Wegovy · XARELTO · XYWAV · ZOSTAVAX
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 5% for family medicine in CA.

Looking for a family medicine specialist in Irvine?
Compare family medicine physicians in the Irvine area by procedure volume, costs, and industry payment transparency.
Browse family medicine physicians nearby

Geographic Context

Family medicine physicians within 10 mi
2,159
Per 100K population
68.2
County median income
$113,702
Nearest hospital
HOAG ORTHOPEDIC INSTITUTE
3.6 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Stasiewicz is a clinical cardiology specialist, with moderate Medicare volume, with low-engagement industry engagement in the top 5% of CA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Stasiewicz experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Stasiewicz performed 224 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Stasiewicz receive payments from pharmaceutical companies?
Yes. Dr. Stasiewicz received a total of $7,728 from 45 companies across 400 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Stasiewicz's costs compare to other family medicine physicians in Irvine?
Dr. Stasiewicz's average Medicare payment per service is $44. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Stasiewicz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →